Silo Pharma, Inc.
Silo Pharma, Inc. scores highest on Torque (60) and lowest on Nitro (14). Its PosiPenta is 41.29 out of 100, around the middle of similar companies.
On the Penta Grid this week, Silo Pharma, Inc. is Grid #491 of 837 in the Healthcare sector in United States, and Grid #2,749 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Silo Pharma, Inc. | 41.29 | 46 | 45 | 14 | 60 | 42 |
| INVO Fertility, Inc. | 43.24 | 98 | 53 | 4 | 39 | 22 |
| Calidi Biotherapeutics, Inc. | 25.19 | 40 | 40 | 5 | 16 | 25 |
| Decoy Therapeutics Inc. | 47.86 | 92 | 50 | 3 | 46 | 48 |
| Sunshine Biopharma, Inc. | 39.57 | 50 | 54 | 4 | 66 | 24 |
| HCW Biologics Inc. | 29.10 | 47 | 41 | 8 | 21 | 29 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.28 |
| P/B ratio | 0.50 |
EEarnings
| Trailing EPS | ₹-403.49 |
| Forward EPS | ₹-66.30 |
NNitro
| Price | 111.76 |
| 52-week high | 987.40 |
| 52-week low | 104.19 |
| Fall from 52-week high | 88.7% |
TTorque
| Return on equity (ROE) | -91.23% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.91 |
| Market cap | ₹22 Cr |
| Insider holding | 8.17% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Silo Pharma, Inc.'s PosiPenta score?
Silo Pharma, Inc.'s PosiPenta is 41.29 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Silo Pharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, Silo Pharma, Inc. is Grid #491 of 837 in the Healthcare sector in United States, and Grid #2,749 of 4,000 in United States.
Which PosiPenta pillar is strongest for Silo Pharma, Inc.?
Torque (durability), with a score of 60 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Silo Pharma, Inc.?
Nitro (momentum), with a score of 14 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.